
- 积分
- 187
- 威望
- 187
- 包包
- 683
|
第一篇:
" q N7 ^# V0 B8 o! S, i% }- ]$ |http://www.ncbi.nlm.nih.gov/pubmed/21393998
( i" f8 ^ m; W; E$ D ^/ ^9 H) D2 q6 x0 Z' ~( y6 q/ X
Cell Cycle. 2011 Apr 1;10(7):1015-6. Epub 2011 Apr 1.
- u _7 H6 F. _) K0 o+ xmTOR upregulation of glycolytic enzymes promotes tumor development.8 Z \. E# ^( `( d! \
Zha X, Sun Q, Zhang H.$ g" w/ F7 o9 D. V
Anhui Medical University; Hefei, China.
( m" t# M' u1 K
4 D' Z6 K2 X( O' e" s第二篇:
2 }& y3 Z1 l. i, d/ @1 J1 vhttp://www.pnas.org/content/108/10/4129.full.pdf+html1 Z' N$ x- t" X$ Y
3 _8 d1 Q. `" p2 a; M! l
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth 8 k" p. C1 i R+ ?3 G
PNAS 2011 108 (10) 4129-4134; published ahead of print February 15, 2011,
/ x: A, \2 C0 I
( }) }: ?, ~( W/ S" I第三篇:
; s! B( ` ]; t- p& shttp://www.nature.com/ncb/journal/v13/n3/abs/ncb2168.html
- }2 [# ^) @, S2 Z' g& g
! M) p3 U& ~' O( f5 q! q. UInactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1
" o5 F# \ `+ r9 kMin Zheng,1 Yan-Hai Wang,1 Xiao-Nan Wu,1 Su-Qin Wu,1 Bao-Ju Lu,2 Meng-Qiu Dong,2 Hongbing Zhang,3 Peiqing Sun,4 Sheng-Cai Lin,1 Kun-Liang Guan5 & Jiahuai Han1 . N. _! d9 o1 q% l
AffiliationsContributionsCorresponding author Journal name:
4 }! ^/ p4 S8 K |Nature Cell Biology Volume:13,Pages:263–272Year published 2011)DOI:doi:10.1038/ncb21680 v5 ^0 i: X" @; M! L. u7 E
, u. T5 P8 F) M& N2 v% O
& v' \) h% w& v. E2 ]5 {第四篇:
( i/ v! P% I! `$ p+ I5 khttp://cancerres.aacrjournals.org/content/71/1/13.abstract+ C" T! B5 h$ t5 j! i- L
; W1 g% F& v% {* J% yLactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis' T+ X" V, v I
Xiaojun Zha1, Fang Wang1, Ying Wang1, Shaozong He1, Yanling Jing1, Xueyan Wu2, and Hongbing Zhang12 I* q, ?/ j% Q! j$ V
8 ?. j% W7 q5 Y/ }
第五篇:
( ?: x8 }5 `& |+ m1 ohttp://gut.bmj.com/content/59/12/1687.full.pdf
* ^5 {3 w- o0 z: V3 L- L% B
4 k7 d4 w4 Z2 CPaper: Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
. z+ @! k+ y# J, P/ mYilei Mao, Huayu Yang, Haifeng Xu, Xin Lu, Xinting Sang, Shunda Du, Haitao Zhao, Wang Chen, Yiyao Xu, Tianyi Chi, Zhiying Yang, Jianqiang Cai, Hui Li, Jianguo Chen, Shouxian Zhong, Smruti R Mohanti, Reynold Lopez-Soler, J Michael Millis, Jiefu Huang, Hongbing Zhang Gut 2010;59:1687-1693 Published Online First: 28 September 2010
( l& y& W4 a5 j, \" H* w' _: n& X$ k+ w4 i& m0 Z0 F: i$ H
第六篇:
! U+ }6 i7 W3 {3 p& }3 A: Bhttp://www.nature.com/emboj/journal/v29/n17/pdf/emboj2010166a.pdf5 x- { s" [5 ?, W3 v
4 P N7 V8 w. R/ a: o; W3 kThe EMBO Journal (2010) 29, 2994 - 3006 doi:10.1038/emboj.2010.1666 K# N" T @2 _ T ~3 |0 e
Published online: 23 July 2010
8 G7 Q o' w& V& F/ L3 G, fS6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response |
|